Evidence map›Paper›PMID 32848851›Full record

ArticleFrontiers in physiology2020

circAFF1 Aggravates Vascular Endothelial Cell Dysfunction Mediated by miR-516b/SAV1/YAP1 Axis.

Hong-Guang Wang, Hua Yan, Chen Wang, Mi-Mi Li, Xin-Ze Lv, Hai-Dong Wu, Zhan-Hai Fang, Dong-Li Mo, Zhi-Yuan Zhang, Bin Liang and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. CircRNA-miRNA interactions in atherogenesis.Molecular and cellular biochemistry · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Hong-Guang WangCollege of Pharmacy, Nankai University, Tianjin, China.
Hua YanDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Chen WangDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China.
Mi-Mi LiTianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Xin-Ze LvDrug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Hai-Dong WuTianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Zhan-Hai FangDepartment of Neurosurgery, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
Dong-Li MoDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China.
Zhi-Yuan ZhangTianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Bin LiangTianjin Institute, of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Ke-Guan LaiDrug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Jing-Yu BaoDrug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Xue-Jia YangDrug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Hong-Juan ZhaoDepartment of Respiratory Medicine, Songjiang Sijing Hospital, Shanghai, China.
Shuang ChenTianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Yi-Mu FanDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Xiao-Guang TongDepartment of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
Tianjin International Joint Academy of Biomedicine · CNTianjin Huanhu Hospital · CNNankai University · CNSongjiang District Central Hospital · CNThe Fourth People's Hospital of Ningxia Hui Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological vascular endothelial damage caused by hypoxia is the basis of many vascular-related diseases. However, the role of circular RNA in hypoxic vascular injury is still poorly understood. Here, we found that hypoxia induced AFF1 circular RNA (circAFF1) can activate the SAV1/YAP1 and lead to the dysfunction of vascular endothelial cells. In HUV-EC-C and HBEC-5i cells, circAFF1 was upregulated under CoCl

Indexed as

circAFF1hypoxicsubarachnoid hemorrhagevascular endothelial cellYAP1

Identifiers

PMID32848851
PMCPMC7425207
OpenAlexW3047481274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.